Evidence map›Paper›PMID 36282119›Full record

Trial reportTranslational vision science & technology2022

Virtual Reality Hemifield Measurements for Corrective Surgery Eligibility in Ptosis Patients: A Pilot Clinical Trial.

Margarita Labkovich, Andrew J Warburton, Stephanie Ying, Aly A Valliani, Nicholas Kissel, Randal A Serafini, Raj Mathew, Megan Paul, S Malin Hovstadius, Vicente N Navarro and 3 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Translational vision science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. The falsies effect: How this beauty trend falsely induces severe glaucoma.American journal of ophthalmology case reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Margarita LabkovichDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Andrew J WarburtonDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Stephanie YingDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Aly A VallianiDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nicholas KisselDepartment of Statistics & Data Science, Carnegie Mellon, Pittsburgh, PA, USA.
Randal A SerafiniDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Raj MathewDepartment of Medical Education, SUNY Downstate, Brooklyn, NY, USA.
Megan PaulDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
S Malin HovstadiusDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Vicente N NavarroDepartment of Uro Onc Research, Weill Cornell Medicine, New York, NY, USA.
Aashay PatelDepartment of Medical Education, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Harsha ReddyDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
James G ChelnisDepartment of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · USAllen Institute for Brain Science · USCarnegie Mellon University · USSUNY Downstate Health Sciences University · USWeill Cornell Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We developed an accelerated virtual reality (VR) suprathreshold hemifield perimetry algorithm, the median cut hemifield test (MCHT). This study examines the ability of the MCHT to determine ptosis severity and its reversibility with an artificial improvement by eyelid taping on an HTC Vive Pro Eye VR headset and the Humphrey visual field analyzer (HVFA) to assess the capabilities of emerging technologies in evaluating ptosis. Methods: In a single visit, the MCHT was administered along with the HVFA 30-2 on ptotic untaped and taped eyelids in a randomized order. The primary end points were a superior field visibility comparison with severity of VF loss and VF improvement after taping for MCHT and HVFA. Secondary end points included evaluating patients' Likert-scaled survey responses on the comfort, speed, and overall experience with both testing modalities. Results: VR's MCHT superior field degrees visible correlated well for severe category margin to reflex distance (r = 0.78) compared with HVFA's (r = -0.21). The MCHT also demonstrated noninferiority (83.3% agreement; P = 1) against HVFA for detection of 30% or more superior visual field improvement after taping, warranting a corrective surgical intervention. In comparing hemi-VF in untaped eyes, both tests demonstrated relative obstruction to the field when comparing normal controls to severe ptosis (HVFA P < 0.05; MCHT P < 0.001), which proved sufficient to demonstrate percent improvement with taping. The secondary end point of patient satisfaction favored VR vision testing presentation mode in terms of comfort (P < 0.01), speed (P < 0.001), and overall experience (P < 0.01). Conclusions: This pilot trial supports the use of MCHT for the quantitative measurement of visual field loss owing to ptosis and the reversibility of ptosis that is tested when conducting a presurgical evaluation. We believe the adoption of MCHT testing in oculoplastic clinics could decrease patient burden and accelerate time to corrective treatment. Translational Relevance: In this study, we look at vision field outputs in patients with ptosis to evaluate its severity and improvement with eyelid taping on a low-profile VR-based technology and compare it with HVFA. Our results demonstrate that alternative, portable technologies such as VR can be used to grade the degree of ptosis and determine whether ptosis surgery could provide a significant superior visual field improvement of 30% or more, all while ensuring a more comfortable experience and faster testing time.

Indexed as

BlepharoptosisVirtual RealityEyelidsHumansPilot ProjectsVisual FieldsVisual Field Tests

Identifiers

PMID36282119
PMCPMC9617504
OpenAlexW4307381113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.